China
Africa
Explore chapters and articles related to this topic
Vitreoretinal Surgery in Rare Conditions
Published in Pradeep Venkatesh, Handbook of Vitreoretinal Surgery, 2023
Iluvien [Alimera Sciences Products] is an elegant injectable, sustained-release device carrying fluocinolone acetonide as the active compound. The drug is compacted into a small cylindrical polyimide tube, 3.5 mm in length and 0.37 mm in diameter. A total of 0.19 mg of the drug gets released at the rate of 0.23–0.45 µg/day over 18 to 36 months. No major surgical incisions are needed, and the device can be injected directly into the eye across the pars plana using a prefilled, 25G needle injector. Post-injection, the implant may behave like a foreign body in the vitreous cavity, and this possibility has to be explained to the patient beforehand. For this reason, it may be preferable to inject this device in the inferotemporal quadrant. Although the device was approved by FDA for treatment of DME in 2014, it is yet to become available in several countries.
Overview of Rehabilitation Technology
Published in Glenn Hedman, Rehabilitation Technology, 2020
These include: Durable Medical Equipment (DME) SupplierDepartment within a Comprehensive Rehabilitation ProgramTechnology Service Delivery Center in a UniversityState Agency-Based ProgramPrivate Rehabilitation Engineering/Technology FirmLocal Affiliate of a National Non-Profit Disability OrganizationMiscellaneous Types of Programs, including Volunteer Groups and Information Resource Centers
Fraud
Published in Julie Dickinson, Anne Meyer, Karen J. Huff, Deborah A. Wipf, Elizabeth K. Zorn, Kathy G. Ferrell, Lisa Mancuso, Marjorie Berg Pugatch, Joanne Walker, Karen Wilkinson, Legal Nurse Consulting Principles and Practices, 2019
The next example involves durable medical equipment (DME). This is a vulnerable area within the healthcare market. One of several rules includes coverage of DME payment and authorization by a licensed healthcare provider. Specifically, it is important to have the referring licensed healthcare provider meet the criteria for reimbursement. In addition, another pattern proves that many times the patient never actually receives the DME.
Experiences with Continuous Positive Airway Pressure Among African American Patients and their Bed Partners
Published in Behavioral Sleep Medicine, 2023
Kristen A. Berg, Marquisha Marbury, Morgan A. Whaley, Adam T. Perzynski, Sanjay R. Patel, J. Daryl Thornton
A total of 30 interviews were conducted across 15 heterosexual African American couples (Table 2). Patients were all married, were predominantly female (80%), were 47.4 ± 8.9 years old, had severe OSA (AHI 36.1 ± 39.3 events/hour), and 9 (60%) were still using CPAP. Of the 15 bed partners, 13 received their care in the study hospital system; 5 (33%) had a diagnosis of OSA and 3 (60%) were using CPAP. We interpreted four primary themes and multiple sub-themes describing the barriers patients and bed partners experienced: 1) inadequate education and support; 2) CPAP maintenance and hygiene; 3) inconvenient design of CPAP interfaces; and 3) impediment to intimacy. We delineated four primary themes, also with sub-themes, describing participants’ experienced facilitators to using CPAP: 1) clinician and durable medical equipment (DME) provider support; 2) properly fitted CPAP masks; 3) active support from partner and family; and 4) experiencing positive results from using CPAP.
Daily Life Experiences: Challenges, Strategies, and Implications for Therapy in Postural Tachycardia Syndrome (POTS)
Published in Occupational Therapy In Health Care, 2022
Emily M. Rich, Asha Vas, Valerie Boyette, Carol Hollingsworth
The most commonly cited strategies were characterized as adapting ADLs and IADLs (1112 times). Modifications through the use of adaptive equipment, positioning for symptom management, delivery services, and safety precautions were utilized. Durable medical equipment (DME), identified by 14.6% of participants, was used with varying frequency. Shower chairs or benches were cited most often to prevent symptom aggravation while bathing. Scooters, walkers, canes, and wheelchairs were used on an as needed basis depending on fluctuating symptoms and distance traveled, while a minority were dependent upon a mobility device at all times. Participants also reported creative ways to perform tasks differently without DME, as this individual reported: “I have to use a cart to lean on and find places to sit and rest during the shopping trips. I have a handicap tag for my car so I can park close.” Other non-DME adaptations included chairs and bar stools which were used to sit while performing activities around the house or placed strategically in the home for safety as needed.
Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of reldesemtiv in ALS: post hoc analyses of a randomized, double-blind, placebo-controlled clinical trial
Published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2022
Stacy A. Rudnicki, Jinsy A. Andrews, Angela Genge, Carlayne Jackson, Noah Lechtzin, Timothy M. Miller, Bettina M. Cockroft, Fady I. Malik, Lisa Meng, Jenny Wei, Andrew A. Wolff, Jeremy M. Shefner
We wished to evaluate the potential health economic impact of reldesemtiv by investigating the time to prescription and acceptance of DME items and the number of patients who were prescribed and agreed to obtain at least one DME item while participating in FORTITUDE-ALS. The DME items specifically recorded were manual wheelchair, power wheelchair, gastrostomy tube, noninvasive ventilator (NIV), or augmentative language device. The endpoint was the time to have the DME prescribed by the physician and accepted by the patient as needed (DME-PAP). This endpoint was selected (rather than the actual receipt of, or first use of the DME) given the relatively short trial duration and the variability across insurance coverages and countries in the time to receive the DME once prescribed.